Relationship Between Short-Term Outcomes and PD-L1 Expression Based on Combined Positive Score and Tumor Proportion Score in Recurrent or Metastatic Head and Neck Cancers Treated With Anti-PD-1 Antibody Monotherapy

Category Primary study
JournalCancer Rep.
Year 2025
This article has no abstract
Epistemonikos ID: 1062036cdbd46fe7614a318cf8e258e64d0c03b0
First added on: Feb 07, 2025